← Back to Search

Other

Diet Management for Acromegaly

N/A
Recruiting
Research Sponsored by Cedars-Sinai Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of acromegaly.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial looks at how diet affects the progression, symptoms, and treatment outcomes of acromegaly.

Who is the study for?
This trial is for individuals who have been diagnosed with acromegaly, a condition often caused by a pituitary gland tumor resulting in excess growth hormone. Participants should not have any existing dietary restrictions that would prevent them from following the specific diet plans used in this study.
What is being tested?
The study is examining how a low carbohydrate and low gluten diet might affect the progression of acromegaly, as well as its symptoms, complications, and how well other treatments work. The goal is to see if these diets can play a role in managing the condition.
What are the potential side effects?
While there are no direct side effects mentioned for this trial since it involves dietary changes rather than medication or surgery, participants may experience changes in digestion or energy levels due to alterations in their usual eating habits.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with acromegaly.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acromegaly
Body Weight Changes
Change in insulin-like growth factor 1 (IGF-1).

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Active Control
Group I: Low glutenActive Control1 Intervention
Counseling, education, and implementation of low gluten diet.
Group II: StandardActive Control1 Intervention
No change/intervention in diet. Continuation of standard diet.
Group III: CarbohydrateActive Control1 Intervention
Counseling, education, and implementation of low carbohydrate diet.

Find a Location

Who is running the clinical trial?

Cedars-Sinai Medical CenterLead Sponsor
513 Previous Clinical Trials
163,380 Total Patients Enrolled
8 Trials studying Acromegaly
354 Patients Enrolled for Acromegaly
~2 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top